• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number ASD44A
Device Problems Expulsion (2933); Positioning Problem (3009)
Patient Problem No Code Available (3191)
Event Date 11/13/2019
Event Type  Injury  
Manufacturer Narrative
Pma/510(k) # : p050006.(b)(4).The gore® cardioform asd occluder instructions for use list device embolization as a potential clinical and device adverse event.Furthermore, the recommended procedures section states: "measure the septal defect using fluoroscopy or echocardiography; the stop flow balloon technique is recommended, as described below: place a contrast filled, compliant balloon across the defect and gently inflate until shunting through the defect has stopped.Measure the diameter of the defect using either echocardiography or calibrated fluoroscopy." additionally, the recommended procedures section states, "the septal tissue margins surrounding the defect must be of sufficient size and integrity to prevent disc prolapse through the defect and gore® cardioform asd occluder embolization.".
 
Event Description
It was reported the physician implanted a 44mm gore® cardioform asd occluder to close an atrial septal defect with a static measurement of 15mm x 23mm and an inferior rim deficiency.The defect was not balloon sized.Approximately two hours following the procedure, the device embolized to the main pulmonary artery.The device was successfully removed with a snare.The defect was then balloon sized (non stop-flow method) to 36mm, and a 36mm amplatzer septal occluder device was implanted with no adverse effects.The physician and a gore field sales associate reviewed implant fluoroscopic imaging and noted that it appeared the device was prolapsing on the inferior rim.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key9447684
MDR Text Key187240173
Report Number2017233-2019-01233
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132636518
UDI-Public00733132636518
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/01/2020
Device Catalogue NumberASD44A
Device Lot Number16562781A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/02/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 YR
Patient Weight44
-
-